Teva Vows Appeal After 4 Copaxone Patents Invalidated
A Delaware federal judge sided Monday with generic-drug makers including Sandoz, Mylan and Pfizer and invalidated four patents for Teva's multiple sclerosis drug Copaxone they were accused of infringing. ...To view the full article, register now.
Already a subscriber? Click here to view full article